Specialist in Emerging Markets Health Care


The Executive


Investment support

Value added

Successful investment track record.


Structured approach using bespoke evaluation tools.


Comprehensive assessment of market and business operations.


High degree of reassurance,  supported by evidence-based analysis and conclusions.

Across the globe spending on health care continues to grow strongly - driven by rapidly aging populations, availability of new technologies, and rising incomes and expectations.  Nowhere is this more evident than in emerging markets.  As a result, the health sector offers potentially very attractive investment, and social, returns – evidenced, in recent years, by scores of listings and the emergence of several international health care companies.  

Policlinik female doc v2

We specialize in support to all phases of the investment/M&A project cycle including:

  • initial project identification and screening

  • due diligence and feasibility analysis

  • negotiations

  • performance improvement and turnaround

  • business strategy formulation and execution


Refined and tested over several years we have developed a robust process for due diligence assessment which encompasses:

  • governance and management

  • market assessment

  • business strategy

  • regulatory environment

  • business model

  • facilities model

  • services model

  • performance (including financial, utilization and efficiency)

  • performance improvement potential

  • growth potential

  • HR/staffing issues

  • risk assessment (including business, clinical, environmental, insurance)

Max building site Arab doctors walking